Targeting of pericyte cells may provide a new target for diabetic retinopathy

A Harvard-led research team have reported an entirely novel target in the pathogenesis of diabetic retinopathy. The research group, led by Dr. George King at the Harvard Medical School, showed that high levels of glucose were capable of quenching a specific growth factor that